메뉴 건너뛰기




Volumn 91, Issue 5, 2011, Pages 542-551

Cardiovascular disease medications after renal transplantation: Results from the patient outcomes in renal transplantation study

Author keywords

Cardiovascular disease; Internationality; Kidney transplantation; Medication

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STATIN;

EID: 79952191331     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31820437bd     Document Type: Article
Times cited : (47)

References (24)
  • 1
    • 53749104371 scopus 로고    scopus 로고
    • 2202 kidney transplant recipients with 10 years of graft function: What happens next?
    • Matas AJ, Gillingham KJ, Humar A, et al. 2202 kidney transplant recipients with 10 years of graft function: What happens next? Am J Transplant 2008; 8: 2410.
    • (2008) Am J Transplant , vol.8 , pp. 2410
    • Matas, A.J.1    Gillingham, K.J.2    Humar, A.3
  • 2
    • 38949158094 scopus 로고    scopus 로고
    • Risk factors for cardiovascular events after successful renal transplantation
    • Vanrenterghem YF, Claes K, Montagnino G, et al. Risk factors for cardiovascular events after successful renal transplantation. Transplantation 2008; 85: 209.
    • (2008) Transplantation , vol.85 , pp. 209
    • Vanrenterghem, Y.F.1    Claes, K.2    Montagnino, G.3
  • 3
    • 0035897696 scopus 로고    scopus 로고
    • Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    • Expert Panel on Detection EaToHBCiA
    • Expert Panel on Detection EaToHBCiA. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 2001, 285, 2486
    • (2001) JAMA , vol.285 , pp. 2486
  • 4
    • 36448930099 scopus 로고    scopus 로고
    • Chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina
    • Fraker TD Jr, Fihn SD, Gibbons RJ, et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 2007; 50: 2264.
    • (2007) J Am Coll Cardiol , vol.50 , pp. 2264
    • Fraker Jr., T.D.1    Fihn, S.D.2    Gibbons, R.J.3
  • 5
    • 10744229858 scopus 로고    scopus 로고
    • Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial
    • Holdaas H, Fellstrom B, Jardine AG, et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial. Lancet 2003; 361: 2024.
    • (2003) Lancet , vol.361 , pp. 2024
    • Holdaas, H.1    Fellstrom, B.2    Jardine, A.G.3
  • 6
    • 79952186375 scopus 로고    scopus 로고
    • Clinical practice guidelines: Complications in cardiovascular disease
    • Accessed September 29, 2010
    • Cassidy M, Richardson D, Jones C. Clinical practice guidelines: Complications in cardiovascular disease. UK Renal Association 2007. Available at: www.renal.org. Accessed September 29, 2010.
    • (2007) UK Renal Association
    • Cassidy, M.1    Richardson, D.2    Jones, C.3
  • 7
    • 3042819708 scopus 로고    scopus 로고
    • K/DOQIclinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease
    • K/DOQIclinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43: S1.
    • (2004) Am J Kidney Dis , vol.43
  • 8
    • 75149181301 scopus 로고    scopus 로고
    • Predicting coronary heart disease after kidney transplantation: Patient outcomes in renal transplantation (PORT) study
    • Israni AK, Snyder JJ, Skeans MA, et al. Predicting coronary heart disease after kidney transplantation: Patient outcomes in renal transplantation (PORT) study. Am J Transplant 2010; 10: 338.
    • (2010) Am J Transplant , vol.10 , pp. 338
    • Israni, A.K.1    Snyder, J.J.2    Skeans, M.A.3
  • 9
    • 33748778507 scopus 로고    scopus 로고
    • Cardiovascular complications after renal transplantation and their prevention
    • Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation 2006; 82: 603.
    • (2006) Transplantation , vol.82 , pp. 603
    • Ojo, A.O.1
  • 10
    • 33846083971 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular diseases in people with diabetes mellitus:Ascientific statement from the American Heart Association and the American Diabetes Association
    • Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus:Ascientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007; 115: 114.
    • (2007) Circulation , vol.115 , pp. 114
    • Buse, J.B.1    Ginsberg, H.N.2    Bakris, G.L.3
  • 11
    • 37849041229 scopus 로고    scopus 로고
    • Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
    • Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008; 51: 210.
    • (2007) J Am Coll Cardiol , vol.51 , pp. 210
    • Antman, E.M.1    Hand, M.2    Armstrong, P.W.3
  • 12
    • 23844465424 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients
    • K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45: S1.
    • (2005) Am J Kidney Dis , vol.45
  • 13
    • 2942592399 scopus 로고    scopus 로고
    • Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: Post-hoc subgroup analyses of the ALERT Study
    • Jardine AG, Holdaas H, Fellstrom B, et al. Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: Post-hoc subgroup analyses of the ALERT Study. Am J Transplant 2004; 4: 988.
    • (2004) Am J Transplant , vol.4 , pp. 988
    • Jardine, A.G.1    Holdaas, H.2    Fellstrom, B.3
  • 14
    • 0036044831 scopus 로고    scopus 로고
    • European best practice guidelines for renal transplantation. Section IV. Long-term management of the transplant recipient. IV. 5.3. Cardiovascular risks. Hyperlipidaemia
    • European best practice guidelines for renal transplantation. Section IV. Long-term management of the transplant recipient. IV. 5.3. Cardiovascular risks. Hyperlipidaemia. Nephrol Dial Transplant 2002; 17(suppl 4): 26.
    • (2002) Nephrol Dial Transplant , vol.17 , Issue.SUPPL. 4 , pp. 26
  • 15
    • 0037379751 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for managing dyslipidemia in chronic kidney disease
    • K/DOQI clinical practice guidelines for managing dyslipidemia in chronic kidney disease. Am J Kidney Dis 2003; 41: S1.
    • (2003) Am J Kidney Dis , vol.41
  • 16
    • 63149173251 scopus 로고    scopus 로고
    • Standards of medical care in diabetes-2009
    • Standards of medical care in diabetes-2009. Diabetes Care 2009; 2(suppl 1): S13.
    • (2009) Diabetes Care , vol.2 , Issue.SUPPL. 1
  • 17
    • 67650941470 scopus 로고    scopus 로고
    • Use of cardioprotective medications in kidney transplant recipients
    • Gaston RS, Kasiske BL, Fieberg AM, et al. Use of cardioprotective medications in kidney transplant recipients. Am J Transplant 2009; 9: 1811.
    • (2009) Am J Transplant , vol.9 , pp. 1811
    • Gaston, R.S.1    Kasiske, B.L.2    Fieberg, A.M.3
  • 18
    • 34247486136 scopus 로고    scopus 로고
    • Comparisons of guidelinerecommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry)
    • Steinberg BA, Steg PG, Bhatt DL, et al. Comparisons of guidelinerecommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry). Am J Cardiol 2007; 99: 1212.
    • (2007) Am J Cardiol , vol.99 , pp. 1212
    • Steinberg, B.A.1    Steg, P.G.2    Bhatt, D.L.3
  • 19
    • 48249095010 scopus 로고    scopus 로고
    • Determinants and patterns of reninangiotensin system inhibitors' prescription in the first year following kidney transplantation
    • Thilly N, Bayat S, Alla F, et al. Determinants and patterns of reninangiotensin system inhibitors' prescription in the first year following kidney transplantation. Clin Transplant 2008; 22: 439.
    • (2008) Clin Transplant , vol.22 , pp. 439
    • Thilly, N.1    Bayat, S.2    Alla, F.3
  • 20
    • 33646198401 scopus 로고    scopus 로고
    • A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period
    • Formica RN Jr, Friedman AL, Lorber MI, et al. A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period. Nephrol Dial Transplant 2006; 21: 1389.
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 1389
    • Formica Jr., R.N.1    Friedman, A.L.2    Lorber, M.I.3
  • 21
    • 37649002657 scopus 로고    scopus 로고
    • Low-dose aspirin in patients with stable cardiovascular disease: A meta-analysis
    • Berger JS, Brown DL, Becker RC. Low-dose aspirin in patients with stable cardiovascular disease: A meta-analysis. Am J Med 2008; 121: 43.
    • (2008) Am J Med , vol.121 , pp. 43
    • Berger, J.S.1    Brown, D.L.2    Becker, R.C.3
  • 22
    • 0034763373 scopus 로고    scopus 로고
    • Aspirin for primary prevention of coronary heart disease: Safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials
    • Sanmuganathan PS, Ghahramani P, Jackson PR, et al. Aspirin for primary prevention of coronary heart disease: Safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart 2001; 85: 265.
    • (2001) Heart , vol.85 , pp. 265
    • Sanmuganathan, P.S.1    Ghahramani, P.2    Jackson, P.R.3
  • 23
    • 3142729178 scopus 로고    scopus 로고
    • Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
    • Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227.
    • (2004) Circulation , vol.110 , pp. 227
    • Grundy, S.M.1    Cleeman, J.I.2    Merz, C.N.3
  • 24
    • 67651012067 scopus 로고    scopus 로고
    • Antihypertensives for kidney transplant recipients: Systematic review and meta-analysis of randomized controlled trials
    • Cross NB, Webster AC, Masson P, et al. Antihypertensives for kidney transplant recipients: Systematic review and meta-analysis of randomized controlled trials. Transplantation 2009; 88: 7.
    • (2009) Transplantation , vol.88 , pp. 7
    • Cross, N.B.1    Webster, A.C.2    Masson, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.